Tenascin-C promotes the repair of cartilage defects in mice.

[1]  A. Sudo,et al.  Role of tenascin-C in articular cartilage , 2018, Modern rheumatology.

[2]  Y. Figenschau,et al.  Co-expression of 1α-hydroxylase and vitamin D receptor in human articular chondrocytes , 2017, BMC Musculoskeletal Disorders.

[3]  A. Sudo,et al.  Effect of tenascin‐C on the repair of full‐thickness osteochondral defects of articular cartilage in rabbits , 2015, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[4]  Toshimichi Yoshida,et al.  Tenascin‐C in Development and Disease of Blood Vessels , 2014, Anatomical record.

[5]  Caroline Tao,et al.  Adipocyte inflammation is essential for healthy adipose tissue expansion and remodeling. , 2014, Cell metabolism.

[6]  R. Wait,et al.  Tenascin-C fragments are endogenous inducers of cartilage matrix degradation , 2011, Rheumatology International.

[7]  A. Sudo,et al.  Distribution and role of tenascin-C in human osteoarthritic cartilage , 2010, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[8]  M. Kashiwagi,et al.  Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease , 2009, Nature Medicine.

[9]  I. Sekiya,et al.  Weekly intra-articular injections of bone morphogenetic protein-7 inhibits osteoarthritis progression , 2008, Arthritis research & therapy.

[10]  B. Dijkmans,et al.  Are biologics more effective than classical disease-modifying antirheumatic drugs? , 2008, Arthritis research & therapy.

[11]  S. Schelling,et al.  Double-knockout of ADAMTS-4 and ADAMTS-5 in mice results in physiologically normal animals and prevents the progression of osteoarthritis. , 2007, Arthritis and rheumatism.

[12]  R. Khokha,et al.  Increased collagen and aggrecan degradation with age in the joints of Timp3(-/-) mice. , 2007, Arthritis and rheumatism.

[13]  G. Burmester,et al.  Synovitis score: discrimination between chronic low‐grade and high‐grade synovitis , 2006, Histopathology.

[14]  H. Ma,et al.  Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis , 2005, Nature.

[15]  A. Sudo,et al.  Tenascin-C concentration in synovial fluid correlates with radiographic progression of knee osteoarthritis. , 2004, The Journal of rheumatology.

[16]  M Kashiwagi,et al.  TIMP-3 Is a Potent Inhibitor of Aggrecanase 1 (ADAM-TS4) and Aggrecanase 2 (ADAM-TS5)* , 2001, The Journal of Biological Chemistry.

[17]  R. Chiquet‐Ehrismann,et al.  Tenascin‐C induced stimulation of chondrogenesis is dependent on the presence of the C‐terminal fibrinogen‐like globular domain , 2000, FEBS letters.

[18]  T. Sakakura,et al.  Involvement of tenascin-C in proliferation and migration of laryngeal carcinoma cells , 1999, Virchows Archiv.

[19]  E. Mackie,et al.  The role of tenascin‐C and related glycoproteins in early chondrogenesis , 1998, Microscopy research and technique.

[20]  F. Blanco,et al.  Differentiation-dependent effects of IL-1 and TGF-beta on human articular chondrocyte proliferation are related to inducible nitric oxide synthase expression. , 1995, Journal of Immunology.

[21]  Joseph M. Mansour,et al.  Mesenchymal Cell-Based Repair of Large Full Thickness Defects of Articular Cartilage , 1994 .

[22]  A. Sudo,et al.  Tenascin-C Prevents Articular Cartilage Degeneration in Murine Osteoarthritis Models , 2018, Cartilage.

[23]  Johanne Martel-Pelletier,et al.  Role of proinflammatory cytokines in the pathophysiology of osteoarthritis , 2011, Nature Reviews Rheumatology.